✦ LIBER ✦

PAR17 CHARACTERIZATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS FOR PATIENTS PRESCRIBED TUMOR NECROSIS FACTOR-ALPHA INHIBITORS

✍ Scribed by K Stockl; M Jarrar; N Tandon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR7 SURVEY OF CURRENT TREATMENT PRACTIC

✍ KM Kamal; SM Madhavan; JAA Hornsby 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Lessons learned in the use of tumor necr

✍ Ted R. Mikuls; Arthur L. Weaver 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 400 KB

PAR4 COST-EFFECTIVENESS OF TUMOR NECROSI

✍ JR. Spalding; JW Hay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

PMS28 COST-UTILITY ANALYSIS OF TUMOR NEC

✍ CM Nguyen; M Mendes; M Bounthavong; M Christopher; AP Morreale 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

PAR17 A COMPARISION OF THERAPEUTIC PERSI

✍ B Tang; O Dabbous; BL Meissner; H Thompson; M Rahman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PAR8 ALTERNATIVE DECISION ANALYSIS MODEL

✍ KM Kamal; LA Miller; SM Madhavan; J Kavookjian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB